(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.41%) $78.06
(0.23%) $2.21
(-0.31%) $2 316.90
(-0.63%) $27.37
(-0.27%) $985.70
(0.16%) $0.931
(0.41%) $10.94
(0.17%) $0.801
(0.02%) $91.46
Live Chart Being Loaded With Signals
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid...
Stats | |
---|---|
Today's Volume | 73 600.00 |
Average Volume | 302 989 |
Market Cap | 24.59B |
EPS | ¥16.76 ( 2024-03-11 ) |
Next earnings date | ( ¥0 ) 2024-06-02 |
Last Dividend | ¥12.00 ( 2023-07-28 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 5.31 |
ATR14 | ¥1.334 (0.15%) |
Volume Correlation
Pharma Foods Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharma Foods Correlation - Currency/Commodity
Pharma Foods Financials
Annual | 2023 |
Revenue: | ¥68.57B |
Gross Profit: | ¥55.28B (80.61 %) |
EPS: | ¥106.70 |
FY | 2023 |
Revenue: | ¥68.57B |
Gross Profit: | ¥55.28B (80.61 %) |
EPS: | ¥106.70 |
FY | 2022 |
Revenue: | ¥60.19B |
Gross Profit: | ¥48.11B (79.93 %) |
EPS: | ¥-12.89 |
FY | 2021 |
Revenue: | ¥46.75B |
Gross Profit: | ¥39.73B (84.97 %) |
EPS: | ¥132.27 |
Financial Reports:
No articles found.
Pharma Foods Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥10.00 (N/A) |
¥0 (N/A) |
¥10.00 (N/A) |
¥0 (N/A) |
¥12.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.50 | 2020-01-30 |
Last Dividend | ¥12.00 | 2023-07-28 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 9 | -- |
Total Paid Out | ¥60.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.93 | -- |
Div. Sustainability Score | 8.02 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 6.14 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
4725.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3965.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3176.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2163.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
9684.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8704.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
7932.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7150.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
6395.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
5352.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0732 | 1.500 | 8.54 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.129 | 1.200 | 5.71 | 6.85 | [0 - 0.3] |
returnOnEquityTTM | 0.528 | 1.500 | 5.24 | 7.86 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.072 | 0.800 | 9.64 | 7.71 | [1 - 3] |
quickRatioTTM | 0.813 | 0.800 | 9.92 | 7.94 | [0.8 - 2.5] |
cashRatioTTM | 0.659 | 1.500 | 7.45 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.538 | -1.500 | 1.038 | -1.557 | [0 - 0.6] |
interestCoverageTTM | 115.92 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 30.09 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 30.09 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.16 | -1.500 | 1.347 | -2.02 | [0 - 2.5] |
grossProfitMarginTTM | 0.798 | 1.000 | 0.0286 | 0.0286 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0926 | 1.000 | -0.148 | -0.148 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0435 | 1.000 | -0.869 | -0.869 | [0.2 - 2] |
assetTurnoverTTM | 1.758 | 0.800 | 1.613 | 1.291 | [0.5 - 2] |
Total Score | 8.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 5.17 | 1.000 | 9.58 | 0 | [1 - 100] |
returnOnEquityTTM | 0.528 | 2.50 | 6.94 | 7.86 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 30.09 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.57 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 30.09 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00557 | 1.500 | -3.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0133 | 1.000 | -2.17 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
Pharma Foods
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators